GTBPVSSOPH• 12 Months (Normalized)
GTBP vs SOPH (GT Biopharma Inc. vs SOPHiA GENETICS SA)
Showing Closing Date Range from Oct 5, 2025 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.1
+764.02%
GT Biopharma Inc.
Normalized Baseline0.00%
SOPH Performance $8.07
+99.26%
SOPHiA GENETICS SA
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+664.76 pts
GTBP outperforming by 664.76 percentage points
GTBPSOPH
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP SOPH
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(249 dates)
| Date | GTBP Price | GTBP Gain (%) | SOPH Price | SOPH Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $6.10 | +764.02% | $8.07 | +99.26% | +664.76% |
| Sep 30, 2026 | $- | $8.38 | +106.91% | - | |
| Sep 29, 2026 | $6.88 | +873.80% | $8.30 | +104.94% | +768.86% |
| Sep 28, 2026 | $6.80 | +863.17% | $8.49 | +109.63% | +753.54% |
| Sep 25, 2026 | $6.89 | +875.92% | $8.34 | +105.93% | +769.99% |
| Sep 24, 2026 | $6.83 | +867.42% | $8.26 | +103.95% | +763.47% |
| Sep 23, 2026 | $7.10 | +905.67% | $8.08 | +99.51% | +806.16% |
| Sep 22, 2026 | $- | $8.07 | +99.26% | - | |
| Sep 21, 2026 | $7.18 | +917.00% | $8.24 | +103.46% | +813.54% |
| Sep 18, 2026 | $7.16 | +914.16% | $8.19 | +102.22% | +811.94% |
| Sep 17, 2026 | $7.49 | +960.91% | $8.53 | +110.62% | +850.29% |
| Sep 16, 2026 | $7.81 | +1006.23% | $7.98 | +96.91% | +909.32% |
| Sep 15, 2026 | $9.00 | +1174.79% | $7.96 | +96.54% | +1078.25% |
| Sep 14, 2026 | $11.63 | +1547.31% | $7.86 | +94.07% | +1453.24% |
| Sep 11, 2026 | $8.61 | +1119.55% | $7.87 | +94.32% | +1025.23% |
Page 1 of 17